Five companies join NIH repurposing program

Five pharmas joined NIH's compound repurposing initiative. Abbott Laboratories (NYSE:ABT); Bristol-Myers Squibb Co. (NYSE:BMY); GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); Johnson & Johnson (NYSE:JNJ); a...